CVS and LLY Related Headlines
Go Back- CVS Adds Lilly's Zepbound To Preferred Drug List In Reversal
- Morgan Stanley Comments Eli Lilly (LLY) and Medicare GLP-1 Obesity Coverage
- Eli Lilly and Novo Nordisk shares fall as CVS opts out of Medicare obesity drug coverage
- CVS Health Opts Out Of Medicare Obesity Drug Coverage Model
- BofA Comments on GLP-1s and Potential Pressure Ahead
